Skip to main content
. Author manuscript; available in PMC: 2022 Aug 19.
Published in final edited form as: Infect Control Hosp Epidemiol. 2019 Sep 16;40(11):1229–1235. doi: 10.1017/ice.2019.236

Table 2.

Univariate Analysis

Variable, Strata Range Hospital-Associated CDI
No. of
CDI
No. of
Admissions
CDI per
10,000
Admissions
P Value
High-risk antibiotic use, day of therapy per 1,000 days present
1st quartile (77–193) 2,902 909,380 31.9 Reference
2nd quartile (194–241) 2,851 837,128 34.1 .0135
3rd quartile (242–295) 2,523 671,853 37.6 <.0001
4th quartile (296–440) 2,029 561,172 36.2 <.0001
Proportion of patients age >65, %
1st quartile (0.14–0.33) 3,080 1,044,253 29.5 Reference
2nd quartile (0.34–0.38) 1,685 556,608 30.3 .3899
3rd quartile (0.39–0.44) 2,823 820,241 34.4 <.0001
4th quartile (0.45–0.65) 2,717 558,431 48.7 <.0001
Community-onset non-hospital-associated (CO-NHA) CDI per 10,000 admissions
1st quartile (3–35) 2,180 965,859 22.6 Reference
2nd quartile (36–56) 2,700 733,345 36.8 <.0001
3rd quartile (57–89) 2,374 644,295 36.8 <.0001
4th quartile (90–273) 3,051 636,034 48.0 <.0001
Average length of stay, days
1st quartile (2.3–3.4) 1,433 524,973 27.3 Reference
2nd quartile (3.5–3.9) 2,213 680,684 32.5 <.0001
3rd quartile (4.0–4.4) 2,898 814,563 35.6 <.0001
4th quartile (4.5–6.0) 3,761 959,313 39.2 <.0001
Proton pump inhibitor use, days of therapy per 1,000 days present
1st quartile (107–265) 2,224 756,480 29.4 Reference
2nd quartile (266–335) 2,610 857,357 30.4 .2262
3rd quartile (336–372) 2,545 641,402 39.7 <.0001
4th quartile (372–701) 2,926 724,294 40.4 <.0001
Hospital teaching status
Nonteaching (n=105) 4,719 1,436,414 32.9 Reference
Teaching (n=66) 5,586 1,543,119 36.2 <.0001
Hospital geographic region
West (n=19) 915 289,972 31.6 Reference
Northeast (n=26) 1,791 418,282 42.8 <.0001
Midwest (n=48) 2,803 808,738 34.7 0.0135
South (n=78) 4,796 1,462,541 32.8 0.2846

Note. CDI, Clostridioides difficile infection.